One of the Listed companies, Navana Pharmaceuticals Ltd has recommended 13% cash Dividend for the year ended June 30, 2023.
In terms of financial performance, the company has reported Earnings Per Share (EPS) of Tk. 3.59 for the year ending June 30, 2021. Net Asset Value (NAV) per share stands at Tk. 40.71.
The Annual General Meeting (AGM) of the company will be held on December 28, through the digital platform. The record date for this has been fixed at November 19.
Share this
